Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05680012 · ClinicalTrials.gov registry record · NA

Tissue Destruction and Healing in Celiac Disease

A NA study of Celiac Disease, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
220
Enrollment target
3
Study locations

NCT05680012 is a NA study of Celiac Disease that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 220 participants, below the 1,971-participant average among 24 other Celiac Disease trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05680012, a NA study of Celiac Disease, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
220 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this clinical study is to learn more about celiac disease pathogenesis and clinical symptoms. In particular, this study will examine the interactions between biological factors such as, intestinal epithelial cells, microbiota, immune system, genetics, and gluten and their effect on celiac disease clinical symptoms, and severity of tissue destruction and its ability to heal in individuals with celiac disease. Information collected in the study will help researchers to generate better resources to advance celiac disease patient care.

Conditions Studied

Celiac Disease

Interventions

  • DIETARY_SUPPLEMENT Gluten containing snack bar

Study Locations (3)

California

  • California Institute of Technology - Pasadena

Illinois

  • The University of Chicago - Chicago

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2023-07-14
Est. Completion 2027-06-30
Phase NA

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05680012

The ClinicalTrials.gov registry entry for NCT05680012 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,971-participant average among 24 other Celiac Disease trials with a reported enrollment target (89% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Celiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Gluten containing snack bar is the first listed.

NCT05680012 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Illinois, Minnesota.

Frequently Asked Questions

What is clinical trial NCT05680012 about?

NCT05680012 is a clinical study titled "Tissue Destruction and Healing in Celiac Disease". The purpose of this clinical study is to learn more about celiac disease pathogenesis and clinical symptoms. In particular, this study will examine the interactions between biological factors such as, intestinal epithelial cells, microbiota, immune system, genetics, and gluten and their effect on ce...

What is the current status of trial NCT05680012?

This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2023-07-14. Estimated completion is 2027-06-30.

What conditions does trial NCT05680012 study?

This clinical trial studies the following conditions: Celiac Disease.

What interventions are being tested in trial NCT05680012?

The interventions under investigation include: Gluten containing snack bar (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT05680012?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05680012 being conducted?

This trial has 3 study locations across California, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Celiac Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Celiac Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.